Xin Yi Selected Research

RNA (Ribonucleic Acid)

1/2022	BRD4770 functions as a novel ferroptosis inhibitor to protect against aortic dissection.
1/2022	The Predictive Value of PAK7 Mutation for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Cancer.
1/2022	Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non-small cell lung cancers.
8/2021	Whole exome and transcriptome sequencing reveal clonal evolution and exhibit immune-related features in metastatic colorectal tumors.
1/2021	An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome.
1/2021	RNA Modification by m6A Methylation in Cardiovascular Disease.
1/2020	Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
2/2015	RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Yi Research Topics

Disease

59	Neoplasms (Cancer) 01/2022 - 12/2007
13	Breast Neoplasms (Breast Cancer) 08/2021 - 05/2008
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2016
10	Inflammation (Inflammations) 04/2022 - 01/2013
10	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 09/2009
9	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2008
7	COVID-19 01/2022 - 06/2020
7	Fibrosis (Cirrhosis) 01/2020 - 11/2013
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
5	Hypoxia (Hypoxemia) 01/2020 - 07/2010
5	Atrial Fibrillation 11/2017 - 11/2013
4	Pain (Aches) 03/2022 - 11/2013
4	Hypertension (High Blood Pressure) 01/2022 - 10/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2015
4	Stomach Neoplasms (Stomach Cancer) 11/2020 - 02/2014
4	Liver Neoplasms (Liver Cancer) 10/2020 - 02/2008
4	Lung Neoplasms (Lung Cancer) 10/2020 - 12/2007
4	Rheumatic Heart Disease (Rheumatic Heart Diseases) 11/2017 - 11/2013
4	Heart Failure 01/2017 - 03/2016
3	Diarrhea 06/2022 - 10/2016
3	Obesity 02/2022 - 01/2015
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2014
3	Thrombosis (Thrombus) 01/2022 - 09/2013
3	Carcinogenesis 01/2022 - 09/2009
3	Osteoarthritis 01/2022 - 11/2020
3	Microsatellite Instability 01/2022 - 01/2020
3	Myocardial Infarction 01/2021 - 01/2014
3	Infections 10/2020 - 10/2016
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 01/2018
3	Ischemic Stroke 05/2019 - 01/2018
3	Virus Diseases (Viral Diseases) 01/2018 - 12/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 08/2014 - 09/2010
2	Colitis 06/2022 - 01/2019
2	Esophageal Squamous Cell Carcinoma 01/2022 - 01/2021
2	Aortic Dissection 01/2022 - 01/2021
2	Leukemia 07/2021 - 10/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 01/2018
2	Glioma (Gliomas) 01/2021 - 05/2017
2	Osteoporosis 01/2021 - 12/2017
2	Adenocarcinoma of Lung 10/2020 - 05/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2020 - 01/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 09/2017
2	Disease Progression 01/2019 - 06/2018
2	Pneumonia (Pneumonitis) 01/2019 - 10/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 10/2014
2	Schizophrenia (Dementia Praecox) 01/2018 - 11/2017

Drug/Important Bio-Agent (IBA)

21	Circulating Tumor DNAIBA 11/2021 - 01/2016
20	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2008
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2009
16	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2013
11	Pharmaceutical PreparationsIBA 09/2021 - 08/2011
8	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2015
7	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
6	Biological ProductsIBA 01/2022 - 06/2016
6	Histones (Histone)IBA 01/2022 - 02/2014
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
5	Immunoglobulin G (IgG)IBA 01/2021 - 01/2019
5	Hormones (Hormone)IBA 01/2020 - 05/2008
5	Indicators and Reagents (Reagents)IBA 10/2016 - 05/2013
5	EnzymesIBA 01/2015 - 11/2011
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2020 - 09/2010
4	Cell-Free Nucleic AcidsIBA 01/2020 - 05/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2018 - 03/2013
3	CytokinesIBA 01/2022 - 07/2018
3	Interleukin-6 (Interleukin 6)IBA 05/2021 - 07/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2015
3	Phosphotransferases (Kinase)IBA 01/2021 - 05/2017
3	Therapeutic UsesIBA 01/2021 - 01/2014
3	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2020 - 01/2013
3	HydrogelsIBA 11/2018 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 06/2013
2	AntibodiesIBA 01/2022 - 01/2019
2	PotassiumIBA 01/2022 - 12/2015
2	Polysaccharides (Glycans)IBA 12/2021 - 07/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 08/2021 - 01/2021
2	Insulin (Novolin)FDA Link 01/2021 - 12/2014
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 11/2013
2	Atorvastatin (Lipitor)FDA Link 01/2021 - 01/2018
2	MelatoninIBA 12/2020 - 04/2015
2	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 02/2008
2	Estrogen ReceptorsIBA 01/2020 - 08/2011
2	human ERBB2 proteinIBA 01/2020 - 05/2019
2	pyrotinibIBA 01/2020 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 10/2016
2	Amino Acids FDA Link 01/2019 - 04/2016
2	CrizotinibIBA 11/2018 - 05/2018
2	azadirachtin (azadirachtin A)IBA 10/2018 - 10/2018
2	LipopolysaccharidesIBA 07/2018 - 04/2015
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 10/2016

Therapy/Procedure

31	Therapeutics 01/2022 - 05/2008
11	Immunotherapy 01/2022 - 01/2017
5	Drug Therapy (Chemotherapy) 12/2021 - 02/2014
4	Radiotherapy 01/2022 - 01/2018
4	Hepatectomy 11/2019 - 10/2012
2	Neoadjuvant Therapy 08/2021 - 01/2020
2	Lasers (Laser) 01/2021 - 06/2014
2	Transplantation 01/2021 - 01/2014
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 08/2020 - 01/2020
2	Aftercare (After-Treatment) 06/2018 - 06/2016